Previous 10 | Next 10 |
CORAL GABLES, Fla., Oct. 06, 2020 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular and neurologic...
Catalyst Pharmaceuticals slides ([[CPRX]] -7.8%) after a federal judge upheld a previous rule from a Magistrate Judge, granted summary judgment in favor of the FDA and Jacobus and dismissed the company’s lawsuit against the FDA regarding the approval of a rival drug, Ruzurgi for t...
CORAL GABLES, Fla., Sept. 29, 2020 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), today reported that the federal judge handling Catalyst's case against the FDA has adopted the previously reported Report and Recommendation of the Magistrate Judge, granted summ...
Aptorum Group Stock Rallies 1,066% Overnight Sparking Momentum For Biotech Penny Stocks If you’re looking for penny stocks to buy right now, you’re probably pretty busy. There’ve been countless breakouts in the energy sector. Additionally, many of these stoc...
Traders on the Robinhood investing app are notorious for picking highly speculative stocks -- and as a group, they're too powerful to ignore if you're considering an investment in smaller biotech companies. Especially in the context of hot equities with millionaire-maker potential, hopping on th...
Shares of the rare-disease drugmaker Catalyst Pharmaceuticals (NASDAQ: CPRX) fell by a staggering 23.7% during the month of August, according to data provided by S&P Global Market Intelligence . Catalyst's shares hit the skids last month following a negative late-stage readout for ...
Most Popular Penny Stocks On Robinhood Right Now When it comes to penny stocks , Robinhood has become a popular platform to use among new traders. This gamified trading tool allows easy access to the stock market. Today, with so many new events influencing the way investors buy and sell, a mo...
Catalyst Pharmaceuticals ( CPRX +1.3% ) and Canada commercialization partner KYE Pharmaceuticals announce the filing of a proceeding in a Canadian federal court challenging Health Canada's approval of Medunik's Ruzurgi (amifampridine) for the treatment of Lambert-Eaton myasthenic sy...
CORAL GABLES, Fla., Aug. 26, 2020 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular and neurologic...
Are You Looking For Top Biotech Stocks To Buy? If Yes, Are These 2 On Your List? Biotech stocks have emerged as a popular asset class to watch this year. More specifically, small-cap biotech stocks are making big moves like never before. For this reason, it is gathering a lot of investor a...
News, Short Squeeze, Breakout and More Instantly...
Catalyst Pharmaceuticals Inc. Company Name:
CPRX Stock Symbol:
NASDAQ Market:
Catalyst Pharmaceuticals Inc. Website:
CORAL GABLES, Fla., July 22, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult-to-...
2024-06-20 17:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-03 11:30:04 ET H.C. Wainwright analyst issues UNDERPERFORM recommendation for CPRX on June 3, 2024 09:00AM ET. The previous analyst recommendation was Underperform. CPRX was trading at $16.38 at issue of the analyst recommendation. The overall analyst consensus :...